JW Holdings Corporation (KRX:096760)
4,030.00
+105.00 (2.68%)
Last updated: Apr 3, 2026, 2:14 PM KST
JW Holdings Revenue
In the year 2025, JW Holdings had annual revenue of 969.57B KRW with 9.22% growth. JW Holdings had revenue of 257.56B in the quarter ending December 31, 2025, with 15.24% growth.
Revenue
969.57B
Revenue Growth
+9.22%
P/S Ratio
0.29
Revenue / Employee
7.63B
Employees
127
Market Cap
278.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 969.57B | 81.86B | 9.22% |
| Dec 31, 2024 | 887.71B | -40.36B | -4.35% |
| Dec 31, 2023 | 928.07B | 63.54B | 7.35% |
| Dec 31, 2022 | 864.54B | 75.60B | 9.58% |
| Dec 31, 2021 | 788.94B | 7.42B | 0.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chong Kun Dang Holdings | 959.01B |
| Huons | 602.21B |
| Samjin Pharmaceuticals | 274.03B |
| Samil Pharmaceutical Co.,Ltd | 215.04B |
| HLB Pharmaceutical | 205.58B |
| Boditech Med | 162.09B |
| Korea United Pharm | 161.44B |
| Yungjin Pharm. | 158.79B |